MarketCap
Facebook
X
Telegram
Land |
 Kanada |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
16.5 M |
Marktkapitalisierung |
$ 150 M |
EBITDA (LTM) |
$ -11.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-0.55 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
- | - | $ 5.72 M | Nasdaq Global Select Market |  China |
 |
FSD Pharma
HUGE
|
- | 5743.5 % | $ 69.7 M | Nasdaq Capital Market | Canada |
 |
BioAtla
BCAB
|
$ 1.74 | 0.64 % | $ 102 M | Nasdaq Global Select Market |  USA |
 |
Catalyst Pharmaceuticals
CPRX
|
- | - | $ 3.85 B | Nasdaq Capital Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
ADiTx Therapeutics
ADTX
|
- | - | $ 374 | Nasdaq Capital Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Apellis Pharmaceuticals
APLS
|
- | - | $ 5.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market |  Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market |  Cayman-islands |
 |
Bio-Path Holdings
BPTH
|
- | - | $ 100 K | Nasdaq Capital Market | USA |
 |
Cara Therapeutics
CARA
|
- | -3.03 % | $ 260 M | Nasdaq Global Market,SPB | USA |
 |
ChromaDex Corporation
CDXC
|
- | -0.88 % | $ 598 M | Nasdaq Capital Market | USA |
 |
Caladrius Biosciences
CLBS
|
- | -16.75 % | $ 25.8 M | Nasdaq Capital Market | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
- | -5.98 % | $ 34.1 M | Nasdaq Capital Market | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
- | -4.36 % | $ 27 M | Nasdaq Capital Market | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
- | 11.68 % | $ 8.97 M | Nasdaq Capital Market | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
- | -5.68 % | $ 8.28 M | Nasdaq Global Market | USA |
 |
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
- | - | $ 661 M | Nasdaq Global Market,SPB | USA |
 |
Evofem Biosciences
EVFM
|
- | 7.55 % | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Eyenovia
EYEN
|
- | 49.81 % | $ 13.2 M | Nasdaq Capital Market | USA |
 |
FibroGen
FGEN
|
- | - | $ 889 M | Nasdaq Global Select Market,SPB | USA |
 |
Homology Medicines
FIXX
|
- | 0.77 % | $ 53.4 M | Nasdaq Global Select Market | USA |
 |
Amicus Therapeutics
FOLD
|
- | - | $ 4.47 B | Nasdaq Global Market,SPB | USA |
 |
Frequency Therapeutics
FREQ
|
- | - | $ 528 M | Nasdaq Global Select Market | USA |
|
Galecto
GLTO
|
- | - | $ 762 M | Nasdaq Global Select Market |  Danmark |
 |
GlycoMimetics
GLYC
|
- | 9357.83 % | $ 1.01 B | Nasdaq Global Market | USA |
 |
Graybug Vision
GRAY
|
- | -11.23 % | $ 9.65 M | Nasdaq Global Market | USA |
|
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | USA |
 |
Happiness Biotech Group Limited
HAPP
|
- | 1.35 % | $ 17.8 M | Nasdaq Capital Market | China |
 |
Hepion Pharmaceuticals
HEPA
|
- | -18.79 % | $ 39.3 K | Nasdaq Capital Market | USA |
 |
Hoth Therapeutics
HOTH
|
- | - | $ 18.8 M | Nasdaq Global Select Market | USA |
 |
IMARA
IMRA
|
- | 15.96 % | $ 663 M | Nasdaq Global Select Market | USA |
 |
KalVista Pharmaceuticals
KALV
|
- | - | $ 1.45 B | Nasdaq Global Select Market | Britain |
 |
KemPharm
KMPH
|
- | -0.34 % | $ 200 M | Nasdaq Capital Market | USA |
 |
Kezar Life Sciences
KZR
|
- | - | $ 53.3 M | Nasdaq Global Select Market | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
- | - | $ 63.4 M | Nasdaq Capital Market | USA |
 |
Magenta Therapeutics
MGTA
|
- | -7.74 % | $ 41.6 M | Nasdaq Global Select Market | USA |
 |
NovaBay Pharmaceuticals
NBY
|
- | - | $ 11.3 M | NYSE American | USA |